Lance Industries, Inc. v. United States

3 Cl. Ct. 762, 1983 U.S. Claims LEXIS 1573
CourtUnited States Court of Claims
DecidedNovember 10, 1983
DocketCongressional Reference No. 2-78
StatusPublished
Cited by9 cases

This text of 3 Cl. Ct. 762 (Lance Industries, Inc. v. United States) is published on Counsel Stack Legal Research, covering United States Court of Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lance Industries, Inc. v. United States, 3 Cl. Ct. 762, 1983 U.S. Claims LEXIS 1573 (cc 1983).

Opinion

REPORT

NETTESHEIM, Hearing Officer:

On October 12, 1978, by S.Res. 545, 95th Cong., 2d Sess. (1978), the Senate referred S. 3451, 95th Cong., 2d Sess. (1978), to the Chief Commissioner of the United States Court of Claims. S. 3451, entitled “A Bill for the Relief of Lance Industries, Incorporated,” proposes that the Secretary pay claimant Lance Industries, Inc. (“claimant”), out of any money in the Treasury not otherwise appropriated,

[t]he sum of $ [blank] in full settlement of its claims against the United States for damages suffered by it as the direct and proximate result of the negligent transmission and publication of false information concerning the company’s principal product, a self-defense chemical compound named “Lance”, by various Federal agencies between September 16, 1977, and February 2, 1978.1

S.Res. 545 resolved that “S.3451 ... together with all accompanying papers, is hereby referred to the Chief Commissioner of the Court of Claims pursuant to sections 1492 and 2509 of title 28, United States Code, for further proceedings in accordance with applicable law.”

Claimant’s petition was filed with the Clerk of the Court of Claims on March 7, 1979, and defendant’s answer was filed on June 5, 1979. Thorough discovery ensued between the parties, and an extensive stipulation of facts was reached. Trial was held on May 9 — 11, 1983; the post-trial briefing was completed on September 15, 1983.

The hearing officer has drawn upon the parties’ factual stipulation, but, due to some disharmony between the stipulation and evidence of record, an independent assessment of the facts has been made. Departure from the stipulation also reflects the hearing officer’s determination of the credibility and demeanor of the witnesses and re-evaluation of those parts of the stipulation that are not supported by documentary evidence. On the basis of the facts established by the evidence, as set forth in this report, it is concluded, and the Senate should be so informed: 1) that claimant was not wronged, because defendant was not negligent; 2) and that therefore no legal or equitable basis to allow recovery exists.

FACTS

BACKGROUND

This congressional reference case arises out of a widely publicized rumor which circulated through federal and state agencies in the latter part of 1976 and early 1977. According to the rumor, a substance known as “Lance” had been introduced into the drug culture and might be encountered by officers engaging in drug investigations. “Lance” was alleged to be a cocaine- or heroin-like substance. Sniffing or simple aerial exposure to the substance, in its most virulent form, reportedly would cause brain damage and tasting would cause instant death. Another version of the rumor warned that “Lance” was being mailed to federal government offices where employees would suffer the same consequences. The debilitating substance proved to be “CS,”2 an irritating, but non-lethal, non-injurious form of tear gas.

The rumor merely would have sounded a false alarm, save that there then existed a [764]*764commercial trademark product Lance with which the warning was identified by the public. Commercial Lance was similar to the product Mace, both containing a solution of CS sold in hand-held aerosol cylinders and used as self-protective devices. For ease of reference, the commercial product is referred to herein as Lance, while the street drug is designated as “Lance.” Although commercial Lance is undisputedly a safe product, the negative publicity associated with “Lance,” generated by the rumor, allegedly destroyed the expanding market for commercial Lance. Claimant’s position is that the United States, although acting without malice, breached its duty of care to claimant by its failure to verify the rumor before republishing it throughout the federal government.

Commercial Lance’s demise due to the “Lance” rumor comprises several episodes. The safety and the ingredients of the commercial product must be discussed, as well as the actual or reported incidents of abuse of the CS compound and the identification of commercial Lance with the reports of abuse. Next treated is the chain of dissemination through the state and federal agencies. Finally, the attempts to verify the reports before republication and the retractions of the warning are set out.

To summarize the critical events, the “Lance” rumor began with confusion over the identification of a substance seized by Alaska State Troopers in September 1976. A report embodying this confusion passed to the National Park Service (the “NPS”), which, in turn, passed it to the Organized Crime Task Force in Killeen, Texas, where it was reinforced by a separate report from the Temple, Texas Police Department. From Texas the rumor passed through United States Army Criminal Investigation Division Command (the “Army CID”) channels to the United States Customs Service. “Customs” put the rumor on the national wire, where it was picked up by a multitude of agencies, including embassies overseas. At this point, reached only a few days after the Army CID’s receipt of the initial report, twists appeared in the rumor. When it became apparent that commercial Lance or CS was not capable of the deadly effects attributed to “Lance,” retractions were issued. By that time, however, the news media had begun to report rumors throughout the country, and the failure of claimant’s business followed.

1. The Product

Claimant presented a 1967 report on CS from the Department of the Army, Edge-wood Arsenal. This report reveals that CS is not a gas, but is a “white, crystalline powder, similar in appearance to talcum powder.” For use as a tear gas, CS must be dispensed into the air. The immediate effects caused by CS are a burning sensation in the eyes, tearing, coughing, and tightness in the chest. The effects last for five to ten minutes after exposure, during which time subjects are incapacitated.

Long before the events giving rise to this reference, the safety of CS had been well documented. Mice, rats, guinea pigs, rabbits, dogs, and monkeys were tested. The results showed that 2,600 times as much CS as is required to affect a man would constitute a fatal dose. The effective dose was rated as 10 to 20 milligrams per cubic meter. The Edgewood Report notes that CS had “never been implicated in any death in man despite repeated use.” In fact, if data collected from more resistant species, such as swine, goats, sheep, and burros were included, the level necessary to reach lethal effects would be 15,000 times the effective dose.

Lance was an aerosol product. Each can contained one and one-fourth ounces material, consisting of one percent CS, acetate solvent, freon, and carbon dioxide as the propellant. Claimant in 1972 had a series of tests conducted by Leberco Laboratories, which concluded that Lance was a substance non-toxic by inhalation as defined in the Federal Hazardous Substances Act, 15 U.S.C. § 1261-1276 (1976). Leberco did not find Lance to be a skin or eye irritant under that law. Claimant also obtained an opinion from the American Humane Association [765]*765in 1975 that its product was not sufficiently irritating to be inhumane to dogs.

In sum, the record is clear, and the parties do not dispute, that Lance and its active ingredient CS constitute a safe, non-lethal, non-injuring irritating product.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Schneiter v. United States
Federal Claims, 2022
Dimare Fresh, Inc. v. United States
118 Fed. Cl. 455 (Federal Claims, 2014)
Banfi Products Corp. v. United States
40 Fed. Cl. 107 (Federal Claims, 1997)
Estate of Braude v. United States
38 Fed. Cl. 476 (Federal Claims, 1997)
INSLAW, Inc. v. United States
35 Fed. Cl. 63 (Federal Claims, 1996)
Land v. United States
29 Fed. Cl. 744 (Federal Claims, 1993)
Paul v. United States
20 Cl. Ct. 236 (Court of Claims, 1990)
California Canners & Growers Ass'n v. United States
7 Cl. Ct. 69 (Court of Claims, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
3 Cl. Ct. 762, 1983 U.S. Claims LEXIS 1573, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lance-industries-inc-v-united-states-cc-1983.